Blunt discusses NIH-funded research on visit to med school
Director of NIH's National Center for Advancing Translational Sciences also met with campus leaders
Michael WorfulDavid H. Perlmutter, MD, executive vice chancellor for medical affairs and dean of the School of Medicine (in foreground, at right), talks about medical research Tuesday, Aug. 8, on the Medical Campus. Listening are Christopher P. Austin, MD, director of the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH), (in foreground at left); Chancellor Mark S. Wrighton (far left); Sen. Roy Blunt (middle); and Laura Friedel, a staffer on the Senate Appropriations Committee.
Michael WorfulBradley Evanoff, MD, director of Washington University’s Institute of Clinical and Translational Sciences; Christopher P. Austin, MD, director of the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH); Chancellor Mark S. Wrighton; Sen. Roy Blunt; and David H. Perlmutter, MD, executive vice chancellor for medical affairs and dean of the School of Medicine, after meeting Tuesday, Aug. 8, to discuss funding for medical research.
Victoria J. Fraser, head of the Department of Medicine, discusses research efforts during a meeting Tuesday, Aug. 8, on the Medical Campus. From the left are Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology; Fraser; David H. Perlmutter, MD, executive vice chancellor for medical affairs and dean of the School of Medicine; and Christopher P. Austin, MD, director of the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH).
E. Holland DurandoDavid H. Perlmutter, MD, executive vice chancellor for medical affairs and dean of the School of Medicine (right) talks with Christopher P. Austin, MD, director of the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH), after a meeting Tuesday, Aug. 8, on the Medical Campus.
